Theranomics
Theranomics is a precision oncology company that combines therapeutics and diagnostics—a theranostic approach—to treat cancer as a disease of the genome. By leveraging multi-omics sciences such as genomics, transcriptomics, proteomics, and metabolomics, the company delivers personalized treatment plans with the correct dosage and timely intervention for each patient. The company has supported over 1,297 families in Mexico through 19+ diagnostic services across multiple states.
- Healthcare Technology
- Biotechnology
- Drug Discovery & Therapeutics
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Cancer is a leading cause of death globally, with nearly 10 million fatalities in 2020 alone. In Mexico, almost half of the 195,499 cancer cases diagnosed that year resulted in death, largely because two out of three cases are detected at advanced stages, which severely limits therapeutic options and reduces patient survival rates.
Solution
Theranomics is committed to making cancer a chronic, manageable disease rather than a terminal one by treating it as a disease of the genome. The company combines therapeutics and diagnostics—a theranostic approach—to deliver precision oncology and personalized medicine. By leveraging advances in multi-omics sciences, including genomics, transcriptomics, proteomics, and metabolomics, Theranomics analyzes the complex molecular mechanisms within each patient's cells. This allows the company to associate a specific, optimized treatment with a single, precise diagnosis, ensuring the correct dosage and timely intervention for each individual's unique condition.
Target Audience
Primary customers are cancer patients and their families in Mexico seeking personalized treatment options, as well as healthcare providers looking for advanced precision oncology solutions.
Features
- Theranostic approach integrating therapeutic and diagnostic strategies for personalized cancer care
- Application of multi-omics sciences (genomics, transcriptomics, proteomics, metabolomics) to understand complex molecular mechanisms
- Focus on delivering individualized treatment with the correct dosage and timely intervention for each patient's specific disease
- 19+ diagnostic services available across multiple states in Mexico
- Proven track record of supporting over 1,297 families in finding a diagnosis through the theranostic approach
- 7 years of experience as a pioneer in theranostic-based precision oncology